# Dexmedetomidine Wound Infiltration in Cesarean Section

> **NCT03382938** · NA · RECRUITING · sponsor: **Attikon Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Ropivacaine
- **DRUG:** Dexmedetomidine - Ropivacaine
- **OTHER:** 0,9% saline

## Key facts

- **NCT ID:** NCT03382938
- **Lead sponsor:** Attikon Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-23
- **Primary completion:** 2025-12-20
- **Final completion:** 2026-11-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03382938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03382938, "Dexmedetomidine Wound Infiltration in Cesarean Section". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03382938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*